E-LIB Suche - Ergebnisse für: van Staveren, Iris L

1

TSC22D1 and PSAP predict clinical outcome of tamoxifen trea..:

Meijer, Danielle ; Jansen, Maurice P. H. M. ; Look, Maxime P....
Breast Cancer Research and Treatment. 113 (2008) 2 - p. 253-260 , 2008

Link: https://doi.org/10.1007/..

2

Downregulation of SIAH2, an ubiquitin E3 ligase, is associa..:

Jansen, Maurice P. H. M. ; Ruigrok-Ritstier, Kirsten ; Dorssers, Lambert C. J....
Breast Cancer Research and Treatment. 116 (2008) 2 - p. 263-271 , 2008

Link: https://doi.org/10.1007/..

3

Mismatch repair and treatment resistance in ovarian cancer:

Helleman, Jozien ; van Staveren, Iris L ; Dinjens, Winand NM...
BMC Cancer. 6 (2006) 1 - p. , 2006

Link: https://doi.org/10.1186/..

4

Molecular profiling of platinum resistant ovarian cancer:

Helleman, Jozien ; Jansen, Maurice P.H.M. ; Span, Paul N....
International Journal of Cancer. 118 (2005) 8 - p. 1963-1971 , 2005

Link: https://doi.org/10.1002/..

5

Associations between common polymorphisms in TP53 and p21WA..:

Powell, Brenda L. ; van Staveren, Iris L. ; Roosken, Paul...
Carcinogenesis. 23 (2002) 2 - p. 311-315 , 2002

Link: https://doi.org/10.1093/..

6

Altered expression of p53 and its regulated proteins in phy..:

Kuenen-Boumeester, Vibeke ; Henzen-Logmans, Sonja C. ; Timmermans, Mieke M....
The Journal of Pathology. 189 (1999) 2 - p. 169-175 , 1999

Link: https://doi.org/10.1002/..

7

Predictive value of SRC-1 for tamoxifen response of recurre..:

Berns, Els M.J.J. ; van Staveren, Iris L. ; Klijn, Jan G.M..
Breast Cancer Research and Treatment. 48 (1998) 1 - p. 87-92 , 1998

Link: https://doi.org/10.1023/..

8

Oncogene amplification and prognosis in breast cancer: Rela..:

Berns, Els M.J.J. ; Foekens, John A. ; van Staveren, Iris L....
Gene. 159 (1995) 1 - p. 11-18 , 1995

Link: https://doi.org/10.1016/..

9

Association between rb‐1 gene alterations and factors of fa..:

Berns, Els M. J. J. ; De Klein, Annelies ; Van Putten, Wim L. J....
International Journal of Cancer. 64 (1995) 2 - p. 140-145 , 1995

Link: https://doi.org/10.1002/..

10

Prevalence of amplification of the oncogenes c-myc, HER2/ne..:

Berns, Els M.J.J. ; Klijn, Jan G.M. ; van Staveren, Iris L....
European Journal of Cancer. 28 (1992) 2-3 - p. 697-700 , 1992

Link: https://doi.org/10.1016/..

11

Downregulation of SIAH2, an ubiquitin E3 ligase, is associa..:

Jansen, Maurice P. H. M ; Ruigrok-Ritstier, Kirsten ; Dorssers, Lambert C. J...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-008-0125-z. , 2008

Link: https://hal.archives-ouv..

12

TSC22D1 and PSAP predict clinical outcome of tamoxifen trea..:

Meijer, Danielle ; Jansen, Maurice P. H. M ; Look, Maxime P...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-008-9934-3. , 2008

Link: https://hal.archives-ouv..

13

Mismatch repair and treatment resistance in ovarian cancer:

Helleman, Jozien ; van Staveren, Iris L ; Dinjens, Winand NM...
http://www.biomedcentral.com/1471-2407/6/201. , 2006

Link: http://www.biomedcentral..

14

Mismatch repair and treatment resistance in ovarian cancer:

Helleman, Jozien ; Staveren, Iris ; Dinjens, Winand...
Helleman , J , Staveren , I , Dinjens , W , van Kuijk , P , Ritstier , K , Graham , P , Burg , MEL , Stoter , G & Berns , E 2006 , ' Mismatch repair and treatment resistance in ovarian cancer ' , BMC Cancer , vol. 6 . https://doi.org/10.1186/1471-2407-6-201. , 2006

Link: https://pure.eur.nl/en/p..

15

Mismatch repair and treatment resistance in ovarian cancer:

van der Burg Maria EL ; Ewing Patricia C ; Ritstier Kirsten...
http://www.biomedcentral.com/1471-2407/6/201. , 2006

Link: https://doi.org/10.1186/..